In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

In 2023, Sanofi jumped the bandwagon with the other two insulin U.S. giants to lower the price of its best-selling insulin product, Lantus (insulin glargine), by 78%. Sanofi said it would cap a ...

LLY’s Weekly Insulin Shot Matches Daily Insulin The QWINT-1 study compared efsitora to daily injections of Sanofi ’s SNY Lantus (insulin glargine) for 52 weeks in T2D patients using basal ...

Before insulin’s discovery in 1921, people with diabetes didn’t live long. A 14-year-old boy dying from diabetes was the first to receive an injection of insulin in 1922.

Administer Tresiba and Lantus subcutaneously once daily at any time of day but at the same time every day. Your healthcare provider may individualize and adjust the dosage of Tresiba and Lantus based ...

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap out-of-pocket costs at $35 for all patients with commercial insurance, which goes into effect ...

GoodRx said on Thursday it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35 through its digital marketplace in the U.S.

Sanofi is taking action and providing Americans who need insulin with the ability to access Lantus in an easy and affordable way, regardless of insurance status.

By visiting GoodRx.com/lantus, patients can access a $35 price coupon for a 30-day supply of Sanofi’s Lantus (insulin glargine injection) 100 Units/mL. The coupons can be redeemed at the 70,000 ...

Sanofi announced on March 16, 2023 that it will cut the US list price of Lantus (insulin glargine injection) 100 units/mL, a widely prescribed insulin, by 78%. The company will also establish a $35 ...